İsteğe bağlı ürün analizi
İzninizle, hangi araştırma yolculuklarının işe yaradığını anlamak için gizliliği gözeten sınırlı analizler kullanırız. Reklam izleyicileri veya oturum kaydı kullanmayız. Bu seçimi Tercihler bölümünden değiştirebilirsiniz. Okuyun Gizlilik Politikası.
The Travelers Companies, Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $75.7B | |
|---|---|---|
| Revenue (ttm) | 48.9B | |
| Net income (ttm) | 8.3B | |
| EPS (ttm) | $38.2 | |
| Shares out | 204.9M | |
| P/E (trailing) | 10.3x | |
| P/E (forward) | 10.4x | |
| Dividend | $5.00 (1.27%) | |
| Volume | 1,147,598 | |
| Beta | 0.44 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $34.82B | $36.88B | $41.36B | $46.42B | $48.83B | +8.8% |
| Gross profit | $9.48B | $8.53B | $8.93B | $12.40B | $14.34B | +10.9% |
| Operating income | $4.80B | $3.71B | $3.75B | $6.57B | $8.22B | +14.4% |
| Net income | $3.66B | $2.84B | $2.99B | $5.00B | $6.29B | +14.5% |
| EPS (diluted) | $14.49 | $11.77 | $12.79 | $21.47 | $27.43 | +17.3% |
| EBITDA | $5.67B | $4.53B | $4.47B | $7.29B | $8.90B | +11.9% |
| R&D | — | — | — | — | — | — |
| SG&A | $4.68B | $4.81B | $5.18B | $5.82B | $6.12B | +7.0% |
Recent company headlines from major financial publishers.
The base case models commercial lines pricing discipline sustaining normalized operating margins above the property and casualty industry benchmark, supported by expense ratio discipline and float reinvestment yields. Underwriting earnings normalize in FY2027 following peak results in FY2026. This trajectory produces a target of $242.21 with a probability of 55.0%, representing a return of -33.3% from $363.04. The case would be disconfirmed if commercial lines renewal rate changes turn negative or severe weather catastrophe losses persistently exceed annual loss budgets.
The bull case assumes commercial and personal lines rate increases consistently exceed loss-cost inflation while automated claim processing keeps expense ratios favorable. Maturing fixed-income securities reinvest into elevated yields, accelerating net investment income and driving return on equity higher, funded by ongoing share repurchases. Under these conditions, the bull case projects a target of $333.38 with an estimated probability of 20.0%, generating an expected return of -8.2% relative to $363.04. This path would be disconfirmed by competitive rate resistance from national scale peers or an abrupt drop in benchmark interest rates.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 6.1% | $251 | $252 | $253 | $255 | $257 |
| 6.6% | $245 | $246 | $247 | $249 | $250 |
| 7.1% | $241 | $241 | $242 | $243 | $244 |
| 7.6% | $236 | $237 | $238 | $238 | $239 |
| 8.1% | $232 | $233 | $233 | $234 | $235 |
Upcoming earnings date and setup when available.
Her ay yayımlanan araştırma sürümünün taşıdığı derecelendirme. Bir derecelendirme, analiz tarihindeki fiyatı gerçeğe uygun değerle karşılaştırır; tahminin doğru çıkıp çıkmadığının kaydı değildir.
| Yıl | Oca | Şub | Mar | Nis | May | Haz | Tem | Ağu | Eyl | Eki | Kas | Ara |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |